Print Friendly, PDF & Email

NCT/Study#

NCT04016805 /

UTX-TGR-208

A Phase 2 Study To Assess The Efficacy And Safety Of Ublituximab And Umbralisib In Subjects With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib Or Venetoclax

DISEASE GROUP:

Lymphoma

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587